Literature DB >> 7828603

Image analysis of the distribution of intraperitoneally administered fluids in patients with ovarian cancer.

C Levenback1, J Curtin, D Johnston, S C Rubin, S Yeh, W Hoskins.   

Abstract

Patients are selected for intraperitoneal chemotherapy based on the condition of the peritoneal cavity and the volume of residual disease, as determined by second-look surgery. Several techniques have been described to assess the distribution of intraperitoneal fluids. They rely on point, as opposed to area, measurements. We performed serial radionuclide scans of 15 patients undergoing intraperitoneal chemo for ovarian cancer. Scans were performed following intraperitoneal administration of 500-1000 ml of 99Tc-labeled human serum albumin in normal saline. Each patient underwent three scans at least 4 weeks apart. Radionuclide scans were digitized for computerized analysis. Area in picture elements (pixels) and optical density (mass) of the 99Tc-labeled regions were determined and analyzed for similarities in the pattern of distribution. Area analysis was used to divide the patients into two groups. Group 2 patients (n = 7) had more patients with < 0.5 cm of residual disease (P = .051) and no evidence of disease (P = 0.1) compared with group 1 patients (n = 8). No differences in overall survival were found (P = 0.21). No objective measurement of distribution of intraperitoneally administered fluids exists. Computer image analysis may be an improvement over static scoring techniques to assess non-invasive imaging studies.

Entities:  

Mesh:

Year:  1994        PMID: 7828603

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  1 in total

1.  A phase I and pharmacokinetic study of intraperitoneal topotecan.

Authors:  L S Hofstra; A M Bos; E G de Vries; A G van der Zee; J H Beijnen; H Rosing; N H Mulder; J G Aalders; P H Willemse
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.